Maki Tanaka

5.0k total citations
192 papers, 3.2k citations indexed

About

Maki Tanaka is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Maki Tanaka has authored 192 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Oncology, 36 papers in Molecular Biology and 34 papers in Genetics. Recurrent topics in Maki Tanaka's work include Virus-based gene therapy research (26 papers), Breast Cancer Treatment Studies (22 papers) and Breast Lesions and Carcinomas (17 papers). Maki Tanaka is often cited by papers focused on Virus-based gene therapy research (26 papers), Breast Cancer Treatment Studies (22 papers) and Breast Lesions and Carcinomas (17 papers). Maki Tanaka collaborates with scholars based in Japan, United States and Hong Kong. Maki Tanaka's co-authors include Dave S.�B. Hoon, Kageaki Kuribayashi, Hiroya Takeuchi, Shigeho Tanaka, Chiaki Tanaka, Rin Yamaguchi, Katsuhisa Kogawa, Tomoki Yamano, Yoshiro Niitsu and Hideki Kasuya and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The Journal of Cell Biology.

In The Last Decade

Maki Tanaka

178 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maki Tanaka Japan 28 1.1k 886 534 486 408 192 3.2k
Jue Wang China 37 1.0k 0.9× 2.0k 2.3× 337 0.6× 761 1.6× 409 1.0× 258 4.8k
Kelvin Y.K. Chan Hong Kong 37 594 0.5× 1.7k 1.9× 659 1.2× 268 0.6× 422 1.0× 132 3.8k
Thierry Moreau France 31 717 0.6× 851 1.0× 231 0.4× 609 1.3× 622 1.5× 101 3.3k
Min Kim South Korea 32 732 0.7× 1.3k 1.5× 289 0.5× 309 0.6× 271 0.7× 219 3.8k
Tsuyoshi Saito Japan 37 785 0.7× 1.6k 1.9× 265 0.5× 572 1.2× 536 1.3× 211 4.2k
Sarah Ellis Australia 34 676 0.6× 2.3k 2.6× 347 0.6× 954 2.0× 438 1.1× 80 4.6k
Geoffrey A. Wood Canada 31 462 0.4× 1.7k 1.9× 468 0.9× 431 0.9× 448 1.1× 112 3.3k
Chia‐Ling Wu Taiwan 25 882 0.8× 1.8k 2.1× 295 0.6× 452 0.9× 318 0.8× 68 3.5k
Hongtao Liu United States 30 929 0.8× 1.2k 1.3× 222 0.4× 1.1k 2.3× 317 0.8× 154 3.6k
Arnold L. Oronsky United States 32 775 0.7× 986 1.1× 249 0.5× 639 1.3× 367 0.9× 114 3.5k

Countries citing papers authored by Maki Tanaka

Since Specialization
Citations

This map shows the geographic impact of Maki Tanaka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maki Tanaka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maki Tanaka more than expected).

Fields of papers citing papers by Maki Tanaka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maki Tanaka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maki Tanaka. The network helps show where Maki Tanaka may publish in the future.

Co-authorship network of co-authors of Maki Tanaka

This figure shows the co-authorship network connecting the top 25 collaborators of Maki Tanaka. A scholar is included among the top collaborators of Maki Tanaka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maki Tanaka. Maki Tanaka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Yamaguchi, Rin, Hironori Kusano, Sachiko Ogasawara, et al.. (2020). Androgen receptor expression is useful to predict the therapeutic effect in HER2-positive breast carcinoma. Breast Cancer Research and Treatment. 184(2). 277–285. 12 indexed citations
3.
Shibata, Tomohiro, Kosuke Watari, Akihiko Kawahara, et al.. (2019). Targeting Phosphorylation of Y-Box–Binding Protein YBX1 by TAS0612 and Everolimus in Overcoming Antiestrogen Resistance. Molecular Cancer Therapeutics. 19(3). 882–894. 47 indexed citations
4.
Tanaka, Chiaki, Maki Tanaka, Shigeru Inoue, Masayuki Okuda, & Shigeho Tanaka. (2019). Gender differences in physical activity and sedentary behavior of Japanese primary school children during school cleaning time, morning recess and lunch recess. BMC Public Health. 19(1). 985–985. 17 indexed citations
5.
Shibata, Tomohiro, Kosuke Watari, Hiroto Izumi, et al.. (2016). Breast Cancer Resistance to Antiestrogens Is Enhanced by Increased ER Degradation and ERBB2 Expression. Cancer Research. 77(2). 545–556. 27 indexed citations
6.
Yamaguchi, Rin, Maki Tanaka, Miki Yamaguchi, et al.. (2016). CD8+ tumor‐infiltrating lymphocytes contribute to spontaneous “healing” in HER2‐positive ductal carcinoma in situ. Cancer Medicine. 5(7). 1607–1618. 26 indexed citations
7.
Ito, Akihiro, Tadashi Ishida, Hiromasa Tachibana, et al.. (2014). Beta lactam plus macrolide antibiotic combination therapy reduces the mortality of community-acquired pneumococcal pneumonia more than beta lactam antibiotics alone. European Respiratory Journal. 44(Suppl 58). P4696–P4696. 2 indexed citations
8.
Ni, Yun‐Bi, Julia Y. Tsang, Siu‐Ki Chan, et al.. (2013). Fibrotic Focus in Breast Carcinomas: Relationship with Prognostic Parameters and Biomarkers. Annals of Surgical Oncology. 20(9). 2842–2849. 40 indexed citations
10.
Yamaguchi, Rin, Maki Tanaka, Gary M. Tse, et al.. (2012). Tumor-infiltrating lymphocytes are important pathologic predictors for neoadjuvant chemotherapy in patients with breast cancer. Human Pathology. 43(10). 1688–1694. 108 indexed citations
11.
Yamaguchi, Miki, et al.. (2012). The Usefulness of Vacuum-assisted Biopsy for Diagnosis of Intracystic Tumor of the Breast. Nihon Nyugan Kenshin Gakkaishi (Journal of Japan Association of Breast Cancer Screening). 21(2). 175–178.
12.
Sagara, Yasuaki, Yoshihiko Kamada, Yutaka Yamamoto, et al.. (2011). Study on the state of implementation of HER2 testing and positive ratios in patients with breast cancer in the Kyushu-Okinawa region of Japan. Breast Cancer. 19(4). 315–320. 1 indexed citations
13.
Koshino, Hisashi, et al.. (2010). New Education Method of Pre-clinical Practice for Prosthetic Treatment for Edentulous Patients. Annals of Japan Prosthodontic Society. 2(1). 1–9.
14.
Shinozaki, Koji, et al.. (2010). A CASE OF MESENTERIC ABSCESS CAUSED BY INGESTED FISH BONE, WHICH WAS SUCCESSFULLY TREATED WITH CONSERVATIVE THERAPY. Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 71(9). 2453–2458.
15.
Harada, Tomoko, et al.. (2010). Effective Dosage of Lactic Fermented Soymilk for Improving Lipid Metabolism in Rats. Nippon Shokuhin Kagaku Kogaku Kaishi. 57(4). 175–179. 2 indexed citations
16.
Yamaguchi, Rin, Maki Tanaka, Toshiro Yokoyama, et al.. (2009). Clinicocytopathology of breast cancers with a ring‐like appearance on ultrasonography and/or magnetic resonance imaging. Pathology International. 60(1). 22–26. 4 indexed citations
17.
Konishi, Emiko, et al.. (2008). Virtue Ethics and Its Implications for Nursing. Journal of Japan Academy of Nursing Science. 28(4). 3–7. 1 indexed citations
18.
Koshino, Hisashi, Toshihiro Hirai, Yuichi Yokoyama, et al.. (2007). Method of Evaluating Masticatory Function at Swallowing Threshold for Complete Denture Wearers. Nihon Hotetsu Shika Gakkai Zasshi. 51(1). 42–48. 2 indexed citations
19.
Mitsuyama, Shoshu, et al.. (2006). Adjuvant therapy for Breast Cancer in Kyushu. Breast Cancer. 13(3). 308–312. 1 indexed citations
20.
Tanaka, Maki, Katsuyuki Fujii, Michiko Tsuji, & Takashi Sawai. (2004). Autoimmune reaction to type II collagen and cartilage degeneration in MRL/Mp- lpr/lpr mouse. Rheumatology International. 24(2). 84–92. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026